Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma
Yung-Yeh Su,1– 3,* Yi-Sheng Liu,4,* Chin-Fu Hsiao,5 Chiun Hsu,6– 8 Li-Tzong Chen1,2,9,10 1National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; 2Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng...
Main Authors: | Su YY, Liu YS, Hsiao CF, Hsu C, Chen LT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-06-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/trial-designs-for-integrating-novel-therapeutics-into-the-management-o-peer-reviewed-fulltext-article-JHC |
Similar Items
-
Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma
by: Jordin Stanneart, et al.
Published: (2024-01-01) -
DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma
by: Chang-Yi Lu, et al.
Published: (2023-09-01) -
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance
by: Filippo Pelizzaro, et al.
Published: (2023-03-01) -
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
by: Xiang-Yuan Luo, et al.
Published: (2021-05-01) -
A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma
by: Claire Faltermeier, et al.
Published: (2015-09-01)